Cost of drugs in 2017 in England dropped 0.41%, but more items dispensed

17 March 2018

In 2017, £9.17 billion ($12.7 billion) was the cost of prescriptions dispensed in England, representing decrease of 0.41% (£37.6 million) from 2016, according to a new report released by NHS Digital, the national information and technology partner of the health and care system. The figure does not take into account discounts, dispensing costs, fees, or the income from prescription charges.

Also in 2017, 1.11 billion prescription items were dispensed in the community, an increase of 0.15% (1.7 million) from 2016

Prescription Cost Analysis, England 2017, details the number of items and the Net Ingredient Cost (NIC) of all prescriptions dispensed in the community in England. This includes all items dispensed by the NHS, except those dispensed in hospitals or on private prescriptions.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK